Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany

Seizure

Volumn 14, Issue 7, 2005, Pages 476-484

  Opp, Joachim ^a,b   Tuxhorn, Ingrid ^b   May, Theodor ^b   Kluger, Gerhard ^c   Wiemer Kruel, Adelheid ^d   Kurlemann, Gerd ^e   Gross Selbeck, Gunther ^f   Rating, Dietz ^g   Brandl, Ulrich ^h   Bettendorf, Ulrich ⁱ   Härtel, Christoph ^j   Korn Merker, Elisabeth ^b  

^a Evangelisches Krankenhaus Oberhausen   (Germany)

^b EPILEPSY CENTER BETHEL   (Germany)

^c Neurological Clinic   (Germany)

^d Epilepsy Center Kork   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f Neurology Center for Children   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

ⁱ Department of Child Neurology ^*  (Germany)

^j UNIVERSITY OF LÜBECK   (Germany)

more..

Author keywords

Children; Drug resistant epilepsy; Efficacy; Levetiracetam; Open label add on study; Tolerability

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM;

ADD ON THERAPY; ADOLESCENT; AGGRESSION; ANOREXIA; APNEA; ARTICLE; BEHAVIOR DISORDER; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FATIGUE; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GERMANY; HANDICAPPED CHILD; HEMORRHAGIC COLITIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; TREMOR; VOMITING;

ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; DRUG EVALUATION; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; MALE; PIRACETAM; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 27644557878     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2005.08.002     Document Type: Article

References (24)

1. E. Ben-Menachem U. Falter Efficacy and tolerability of Levetiracetam 3000 mg/day in patients with refractory partial seizures: A multicenter double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group Epilepsia 41 10 2000 1276-1283
2. J.J. Cereghino V. Biton B. Abou-Khalil F. Dreifuss L.J. Gauer I. Leppik et al. for the United States Study Group Levetiracetam for partial seizures: Results of a double blind, randomized clinical trial Neurology 55 2 2000 236-242
3. S.D. Shorvon A. Lowenthal D. Janz E. Bielen P. Loiseau For the European Levetiracetam Study Group Multicenter double-blind, randomized, placebo-controlled trial of Levetiracetam as add-on therapy in patients with refractory partial seizures Epilepsia 41 2000 1179-1186
4. J.M. Pellock T.A. Glauser E.M. Bebin N.B. Fountain F.J. Ritter R.M. Coupez et al. Pharmacokinetic study of Levetiracetam in children Epilepsia 42 2002 1574-1579
5. M. Mula M.R. Trimble M.A.S. Sander Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam Seizure 13 2004 55-57
6. H. Weyrheter J. Buchholt P. Uldall Treatment with levetiracetam in childhood epilepsies according to classification Epilepsia 43 Suppl. 8 2003 184
7. S.L. Kugler I. Patel D. Mandelbaum K.R. Kaufmann E. Wenger J.B. Wollack et al. Behavioural profile of levetiracetam in children Epilepsia 43 Suppl. 7 2002 9
8. M.C. Gustafson F.J. Ritter M.D. Frost V. Karney C. Hoskin Behavioural and emotional effects of Levetiracetam in children with epilepsy Epilepsia 43 Suppl. 7 2002 58-59
9. T. Bosman K. Vonck P. Claeys H. van Vlierberghe M. de Clercq J. de Reuck et al. Enterocolitis: An adverse event in refractory epilepsy patients treated with levetiracetam? Seizure 13 2004 76-81
10. G. Coppola Levetiracetam during 1-year follow up in children, adolescents, and young adults with refractory epilepsy Epilepsy Res 59 2004 35-42
11. B.D.F. Bourgeois D.L. Holder I. Valencia G.L. Holmes J.J. Riviello E.A. Thiele et al. Open label assessment of levetiracetam efficacy and adverse events in a pediatric population Epilepsia 42 Suppl. 7 2001 53-54
12. L. Lagae G. Buyse A. Deconinck B. Ceulemans Effect of levetiracetam in refractory childhood epilepsy syndromes Eur J Paediatr Neurol 7 2003 123-128
13. M. Nieto Barrera Efficacy of levetiracetam in children with partial seizures Epilepsia 45 Suppl. 3 2004 143
14. M. Veendrick-Meekes W.O. Renier L.T. Oei D. Lambrechts Levetiracetam therapy in children and adolescents with intractable epilepsy Epilepsia 43 Suppl. 7 2002 37
15. J.J. Garcia-Peňas Efficacy of levetiracetam as add-on therapy for 51 children with refractory epilepsy Epilepsia 45 Suppl. 3 2004 144
16. T.A. Glauser J.M. Pellock E.M. Bebin Efficacy and safety of levetiracetam in children with partial seizures: An open label trial Epilepsia 43 2002 518-524
17. J.L. Herranz Adjunctive levetiracetam in 133 children with pharmacoresistant epileptic seizures Epilepsia 45 Suppl. 3 2004 144
18. S.R. Mordekar Levetiracetam in children with intractable epilepsy: Preliminary results of a clinical audit Epilepsia 45 Suppl. 3 2004 143
19. A. Papavasiliou Levetiracetam in childhood treatment-resistant epilepsy Epilepsia 45 Suppl. 3 2004 144-145
20. M.J. Tan R.E. Appelton Efficacy and tolerability of levetiracetam in children aged ten years and younger: A clinical experience Seizure 13 2004 142-145
21. E. Nakken A.S. Erikson R. Lossius S.I. Johannessen A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy Seizure 12 2003 42-46
22. J.W. Wannag V.T. Ng Levetiracetam in refractory pediatric epilepsy J Child Neurol 17 2002 413-415
23. K. Krakow M. Walker C. Otoul J.W.A.S. Sander Long-term continuation of levetiracetam in patients with refractory epilepsy Neurology 56 2001 1772-1774
24. J.W. Wheless Y.T. Ng Levetiracetam in refractory pediatric epilepsy J Child Neurol 17 2002 413-415